Photoluminescent NaYF(4):Yb(3+)/Tm(3+) nanocrystals are ideally suited for in vitro and in vivo photoluminescence (PL) bioimaging due to their virtue of near-infrared to near-infrared (NIR-to-NIR) upconversion (UC); they display PL with a peak at approximately 800 nm if excited at approximately 980 nm. Here, we report the synthesis of monodisperse NaYF(4):Yb(3+)/Tm(3+) nanocrystals of ultrasmall size (7-10 nm) with high UC efficiency. The intensity of their NIR UC emission was demonstrated to increase by up to 43 times along with an increase in the relative content of Yb(3+) ions from 20 to 100%, with a corresponding decrease in the Y(3+) content from 80 to 0%. The achieved ultrasmall NaYbF(4):2% Tm(3+) nanocrystals manifest NIR PL emission, which is 3.6 times more intense than that from 25-30 nm sized NaYF(4):20% Yb(3+)/2% Tm(3+) nanocrystals, previously synthesized and used for in vitro and in vivo bioimaging. An optimization of both size and UC PL efficiency of NIR-to-NIR nanocrystals provides us with highly efficient optical imaging probes for bioapplications.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: